Posted inBiotechnology
Posted inBiotechnology
Apollomics, after giving up on GlycoMimetics’ leukemia therapy, posts drug’s latest phase 3 fail
The failure of a myeloid leukemia drug in a phase 3 trial in China isn’t a shock to Apollomics, which…


















